PROJECT

Innfos Technology

百慕迪生命核(R7)

自从人类在地球诞生以来,人体就像一台超级复杂的生物智能电脑系统,不分昼夜,不间断地运行。人体的大脑对接收到的各种生理反馈信号进行动态处理,然后通过自有的生理运行程序,指挥身体各器官进行精确运作。

由丰富血管组织构成的循环系统是人体内最大的器官之一。“R7”技术通过促进内皮祖细胞的数量和功能增加,促进新的血管组织生成,从而改善和恢复自身的心血管正常供血功能。上海复旦大学药学院对生命核的测试结果显示,经过每次8分钟的刺激,体外培养的人脐静脉内皮细胞增殖与对照组相比具有明显的增加,且具有统计学意义;原发性高血压大鼠的动物实验证实,经过“R7”技术Bioboosti的刺激,大鼠血压明显下降;对BaCl2诱导的大鼠室性心率失常试验结果显示,该技术可以明显缩短大鼠心律失常的时间。上海交通大学医学院附属新华医院所进行的“R7”技术对内皮细胞的改善试验研究结果显示,该技术可明显增强大鼠左心室的功能,可明显增加急性心梗大鼠的内皮祖细胞数量和功能,促进促血管生成因子如内皮生长因子、一氧化氮和一氧化氮合酶的明显增加。中国人民解放军第二军医大学进行的“R7”技术对肠易激综合症(IBS)的影响研究结果表明,该技术对大鼠IBS结肠炎具有显著的治疗效果。上海交通大学医学院附属新华医院和上海市徐汇区中心医院的临床试验结果显示,“R7”技术可明显降低原发性高血压患者的血压。“R7”技术可在短时间内不开刀、不吃药、无痛苦地促进受损血管组织再生,这必将引领全球心血管疾病治疗朝着人体自身受损心血管再生疗法的新方向快速发展。

“R7” Bioboosti基于脉冲电磁场(PEMF)领域的生物电磁场(BEM)微生波技术,由美国Biomobie实验中心的生物生化专家、电子电路集成专家、通讯系统工程专家以及多个医疗专业专家联合研发。根据劳宫穴和涌泉穴的临床功效,积分波微磁场治疗仪应用特定波形的积分脉冲微磁场,作用于劳宫穴及涌泉穴,通过对这两个穴位的按压作用和在这两个穴位产生感应微电流、改变细胞膜通透性、扩张血管和增加微循环血流量,对轻中度原发性高血压病服药患者起到调节血压的作用。经过前辈科学家在该领域近半个世纪的不断探索,“R7”技术终于把PEMF领域的BEM微生波生命科技推上了一个崭新的实用阶段。就像由IBM当年巨大而笨重的第一代电脑发展至今的“掌上型”电脑一样,美国硅谷Biomobie的研究团队经过数年无数次的反复实验和不断的系统升级,成功地研发出了具有特定脉冲微磁场波形数学模型的生命核-Bioboosti系统。这一系统包括两大数据库平台,一个是受损器官再生修复数据库平台,又称“再生密码因子厍”;另一个是预防和治疗疾病的配方数据库平台,又称“生物电子医药库”。这两大数据库可供医学专家通过个人电脑随时进入选用。

“R7” Bioboosti是人类延缓衰老、预防和治疗疾病的划时代创新生命科技技术,是人类在人体再生医学领域的重大突破。R7除了在心血管疾病康复领域的特殊疗效外,在其它器官修复、亚健康康复的临床应用上也展示了巨大的潜力。“R7” Bioboosti技术的多项专利科研成果必将使数以亿计的现代人从中获益。

在美国百慕迪实验中心,“R7” Bioboosti技术己取得了可喜的多项实验研究成果。百慕迪Biomobie正在与中国各著名大学的心血管领域专家以及各大医疗机构合作,开展心血管领域更大规模的临床冶疗,开拓一个崭新的心血管疾病和亚健康人群的康复之路。


Ever since humans first came into being in this planet, the human body has evolved to a highly complicated and organized organism consisting of all necessary parts (organs) governed by the brain with unbelievably advanced intelligence, in a sense like an ultra-sophisticated, bio-intelligence-bearing super computer system, which is running uninterruptedly day and night during its whole lifespan. The human brain possesses various innate programs just like the softwares installed in a computer; it performs dynamic processing on various bio-feedback signals it continuously receives, and subsequently sends commands to various organs of the body which work independently but interactively in a precisely coordinated manner according to the inherent physiological programs in the brain. The program for regeneration and rejuvenation of the aged and damaged organs is merely one of thousands of such intrinsic programs imprinted in human brain.

One of the largest organ systems in the human body is the circulation system constituted by heart and a large network of vessels. By arousing the inherent cardiovascular regeneration program in the brain to activate the vascular endothelial cells, Bioboosti helps building new vessels in the human body, thereby improving and restoring the normal blood supply to the entire body. The research data on Bioboosti collected by the researchers in the School of Pharmacy, Fudan University, Shanghai, clearly demonstrated that after eight-minute stimulation with Bioboosti, the growth rate of the cultured human vascular endothelial cells was increased up to 25%. A substantial drop in the blood pressure was observed in the Spontaneously Hypertensive (SHR) rats following three-day treatment with Bioboosti. Similar beneficial effects have also been consistently seen in rat models of cardiac arrhythmias and myocardial infarction. The results from our clinical trials showed that bradycardia, tachycardia and premature ventricular beats were suppressed in 95% of the patients who had received Bioboosti treatment for 7 to 15 days. A clinical report by the Xinhua Hospital of Shanghai Jiao Tong University revealed that after 30-day therapy with Bioboosti, the beats with abnormally prolonged R-R interval of the patients with sick sinus syndrome dropped from 17,380 to 318 times with 24-hour holter. After 30- to 60-day treatment, the cardiac electrophysiological function in 92% of the patients with myocardial ischemia and infarction recovered significantly. The eminent anti-inflammatory efficacy of Bioboosti has also been demonstrated in laboratory research as well as clinical practice. For instance, it has strong efficacy in reducing the level of an inflammatory factor C-reactive protein (CRP) during heart attack and in activating the immune leukocytes. Bioboosti effectively improves micro-circulation by promoting angiogenesis of the capillary vessels. It is also the most effective therapeutic approach for microcirculation disorders such as sexual dysfunction and varicose veins. Bioboosti can promote the regeneration of injured blood vessels and improve blood supply in a short period of time free from pain and without the need for surgery and medication. With the success of this therapeutic approach, the treatment of cardiovascular diseases will surely and rapidly advance in the new direction featuring the regeneration of damaged vascular tissues. Bioboosti has the regeneration capacity for the damaged nervous system and clinical trials have proven its effectiveness in the rehabilitation of patients with hemiplegia and stroke.

Bioboosti was jointly developed, based on the Biological Electromagnetic (BEM) microbial wave technology of the Pulsed Electromagnetic Field Therapy (PEMF), by the experts in biological and biochemical sciences, electronics and integrated circuits, communication systems engineering, and various medical disciplines from the Biomobie Experimental Center in USA. Drawing upon constant exploration by scientists of the older generation for nearly a half century, Bioboosti has ultimately pushed the BEM microbial wave biotechnology of the PEMF into a new stage for practical use. Just like the way how the first generation IBM huge and bulky computers evolved into today's personal digital assistant (PDA), the Biomobie research team based in the Silicon Valley of the United States has succeeded, after years of numerous experiments and constant system upgrading, in the development of Bioboosti system with the capability and capacity for real-time and dynamic regeneration of injured vessel and nerve, viral suppression and disease treatment. This system integrates one control terminal, two supporting terminal database platforms, one communication channel, and one portable intelligent treatment terminal. The control terminal of Bioboosti can be remotely controlled by the medical experts to conduct, through the portable terminal, the classified and individualized regenerative activation, viral suppression, and disease treatment of the damaged tissues. The control terminal of Bioboosti consists of two platforms, i.e. the database platform for regeneration and repairing of damaged organs, which is also known as the “Regeneration Coding Factor Bank”, and the prescription database platform for the inhibition of viral growth and treatment of diseases, which is also known as the “Bio-electronic Pharmaceutics Bank”. These two databases can be accessed by medical experts at any time through PC.

Bioboosti is an epochal, innovative product of life science and technology for human anti-aging, as well as prevention and treatment of diseases; it is a major breakthrough for mankind in the field of human body regenerative medicine. In addition to the special curative effect in the field of cardiovascular disease rehabilitation, Bioboosti also shows the great potential in the clinical application during the repair of other organs and the sub-health rehabilitation. Many patented scientific achievements of Bioboosti will certainly benefit hundreds of millions of modern people.

In the Biomobie Experimental Center based in USA, Bioboosti has made a number of gratifying research achievements. In China, Biomobie has been working with other cardiovascular experts from several prestigious universities and medical institutions in an attempt to achieve a larger scale of treatment of cardiovascular disease and to open up a new path towards rehabilitation of the patients suffering from cardiovascular disease and the sub-healthy population as well.

 

Biomobie 全部产品细节都已经过国家专利版权保护
未经授权不得以任何方式盗用或模仿
违者必究

Biomobie all product details have been over the nationanl patent copyright protection Without authorization
shall not be used in any way to steal or imitate
Those who violate the law will be subject to legal sa

Biomobie (shanghai) Regenerative Medicine co., Ltd.

扫描二维码分享到微信